The order follows three years of close collaboration between Bluewater Bio and Severn Trent, when HYBACS was evaluated in a containerised demonstration plant at Coleshill STW in Birmingham.
Mark Jones, Waste Water R&D Manager for Severn Trent, said: “Rarely do we come across such novel technologies as HYBACS and following an extensive and lengthy on-site evaluation we were convinced that this could provide real cost effective solutions to the challenges we face. We believe that HYBACS has great potential, especially as a ‘slot in’ process for the upgrading of existing sites due to its low operational cost and small additional hydraulic head requirements.”
The overall plant upgrade is being carried out by MWH Treatment. The work should be completed in May 2012.